$8.33 B
๐Ÿ‡จ๐Ÿ‡ณ China
Share price
Change (1 day)
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Market capitalization of Sinopharm (1099.HK)

Market cap: $8.33 Billion

As of September 2021 Sinopharm has a market cap of $8.33 Billion. This makes Sinopharm the world's 1772th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of Sinopharm from 2009 to 2021

Year Market cap Change
2021$7.60 B5.74%
2020$7.19 B-33.85%
2019$10.86 B-13.53%
2018$12.57 B4.53%
2017$12.02 B5.79%
2016$11.36 B2.73%
2015$11.06 B13.3%
2014$9.76 B32.92%
2013$7.34 B-1.92%
2012$7.49 B29.96%
2011$5.76 B-26.95%
2010$7.89 B-1.63%
2009$8.02 B